Overview
SION market data
Price History
SION price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.88 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.37 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $16.38 – $51.57 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $2.1K · P/B 5.98.
Company News
Sionna Therapeutics to Participate in Upcoming June 2026 Investor ConferencesGlobenewswire Inc · May 27, 2026, 12:15 PM
Citizens Reiterates Market Outperform on Sionna Therapeutics, Maintains $63 Price TargetBenzinga · May 26, 2026, 1:24 PM
Stifel Maintains Buy on Sionna Therapeutics, Raises Price Target to $55Benzinga · May 18, 2026, 5:00 PM
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare ConferenceGlobenewswire Inc · May 13, 2026, 12:15 PM
BTIG Reiterates Buy on Sionna Therapeutics, Maintains $58 Price TargetBenzinga · May 13, 2026, 9:30 AM
8-K filing — Sionna Therapeutics, Inc. (SION)SEC EDGAR · May 12, 2026, 11:08 AM